Current Seminars

23/02/2016 - 18:30 - Biopartnering Seminar Series - Biosimilars and the Patent Landscape in Canada

Tuesday, February 23, 2016, 6:30pm. Room 120, Instructional Building. Guest Speaker: Geoffrey D. Mowatt, Partner, Dimock Stratton LLP Biosimilars and the Patent Landscape in Canada In 2010, Health Canada provided an approval pathway for biosimilars in Canada—a rapidly growing and emerging segment in the global...

09/02/2016 - 18:30 - Biopartnering Seminar Series - How Technology Eats Bureaucracy

Tuesday, February 9, 2016, 6:30pm. Room 120, Instructional Building. Guest Speaker: Leerom Segal - Co-Founder & CEO, Klick Inc. HOW TECHNOLOGY EATS BUREAUCRACY Meet Leerom Segal, co-author of the New York Times Bestseller The Decoded Company as he reveals how Klick Health and a growing number of industry-leading companies are turning...

02/02/2016 - 18:30 - Biopartnering Seminar Series - The Evolving Role of Pharmacy Benefit Managers (PBMs) in the Canadian Drug Industry

Tuesday, February 2, 2016, 6:30pm. Room 120, Instructional Building. Guest Speaker: Michael G. Biskey - President, Express Scripts Canada The Evolving Role of Pharmacy Benefit Managers (PBMs) in the Canadian Drug Industry While most Canadians are unaware that Pharmacy Benefit Managers (PBMs) even exist, they play a critical role in...

26/01/2016 - 18:30 - Biopartnering Seminar Series - Brief History of Biofuels

Tuesday, January 26, 2016, 6:30pm. Room 120, Instructional Building. Guest Speaker: Constantin Delibas - Senior Process Engineer, Woodland Biofuels Inc. Brief History of Biofuels Biofuels could replace fossil fuels in the near future bringing both environmental and economic benefits in the process. Biofuels currently used are obtained...

19/01/2016 - 18:30 - Biopartnering Seminar Series - A view of the Pharmaceutical Industry - from a Regulatory Perspective

Tuesday, January 19, 2016, 6:30pm. Room 120, Instructional Building. Guest Speaker: Karen Feltmate - President, Redstone Health Group A view of the Pharmaceutical Industry - from a Regulatory Perspective Abstract: It is often said that the Pharmaceutical industry is one of the heaviest regulated industries but relatively little is...

Pages